Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Follicular Lymphoma Targeted Therapy

Nathan Fowler

MD

🏢MD Anderson Cancer Center🌐USA

Professor, Department of Lymphoma/Myeloma

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nathan Fowler is a leading follicular lymphoma researcher who has advanced targeted therapies including EZH2 inhibitors and lenalidomide-rituximab combinations. His work on tazemetostat for EZH2-mutant follicular lymphoma has established epigenetic therapy as a treatment option. He leads clinical trials evaluating novel combination strategies for indolent lymphomas.

Share:

🧪Research Fields 研究领域

Follicular lymphoma treatment
EZH2 inhibitors
Tazemetostat
Lenalidomide-rituximab
Lymphoma clinical trials

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Nathan Fowler 的研究动态

Follow Nathan Fowler's research updates

留下邮箱,当我们发布与 Nathan Fowler(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment